Real-world experience of adjunct weekly semaglutide in Type 1 diabetes. Is it worth it?

This publication has 7 references indexed in Scilit:

• Impact of semaglutide and dulaglutide shortages on Pharmaceutical Benefits Scheme prescriptions supplied for type 2 diabetes treatment
  Australian Journal of General Practice, 2024
• Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review
  Graefe's Archive for Clinical and Experimental Ophthalmology, 2023
• Clinical and Safety Outcomes With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study
  The Journal of Clinical Endocrinology & Metabolism, 2022
• Adjunct therapies in treatment of type 1 diabetes
  Journal of Diabetes, 2020
• A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin?
  Diabetes Therapy, 2017
• A new model to estimate insulin resistance via clinical parameters in adults with type 1 diabetes
  Diabetes/Metabolism Research and Reviews, 2017
• The metabolic syndrome in type 1 diabetes: does it exist and does it matter?
  Journal of Diabetes and its Complications, 2008